Mga Batayang Estadistika
| CIK | 1128189 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to ProtoKinetix, Incorporated
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| September 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A CONSENT SOLICITATION PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Check the appropriate box: [X] Preliminary Proxy Statement [ ] Confidential, for use of the Commission only as permitted by Rule 14a-6(e)(2) [ ] Definitive Proxy Statement [ ] Definitive Additional Material [ ] S |
|
| August 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-32917 PROTOKINETIX, INCORPORAT |
|
| May 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-32917 PROTOKINETIX, INCORPORA |
|
| May 15, 2025 |
EXHIBIT 4.5 WARRANT AGREEMENT Neither THE WARRANT, NOR THE SHARES UNDERLYING THE WARRANT, GRANTED HEREUNDER TO WHICH THIS WARRANT AGREEMENT RELATES HAVE BEEN REGISTERED UNDER THE securities act of 1933, as amended (the “1933 Act”) AND, UNLESS SO REGISTERED, NONE MAY BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER THE 1933 ACT, PURSUANT TO A |
|
| March 28, 2025 |
Insider Trading Policy adopted July 8, 2019 Exhibit 19.1 protokinetix, Incorporated INSIDER TRADING POLICY Adopted by the Board of Directors on July 8, 2019 PURPOSES This Insider Trading Policy is being adopted in order to assure compliance with the laws prohibiting “insider trading” in Company Securities, including Derivative Securities, and to avoid the appearance of impropriety and resulting damage to the Company’s reputation for integri |
|
| March 28, 2025 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INCORPORATED (Name of |
|
| March 28, 2025 |
Policy on Trading Blackout Periods adopted July 8, 2019 Exhibit 19.2 protokinetix, Incorporated POLICY ON TRADING BLACKOUT PERIODS; BENEFIT PLANS; AND SECTION 16 REPORTING This Policy was unanimously adopted by the Board of Directors of ProtoKinetix, Incorporated on July 8, 2019. It applies to the directors, certain executive officers and certain accounting personnel and consultants of the Company. ProtoKinetix, Incorporated (the “Company”) has adopted |
|
| March 28, 2025 |
Description of Capital Stock of the Company EXHIBIT 4.6 DESCRIPTION OF OUR SECURITIES The following description summarizes important terms of our capital stock and our other securities. For a complete description, you should refer to our Articles of Incorporation and bylaws, forms of which are incorporated by reference to the exhibits to the annual report of which this is a part, as well as the relevant portions of the Nevada Revised Statut |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-32917 PROTOKINETIX, INCOR |
|
| July 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-32917 PROTOKINETIX, INCORPORAT |
|
| June 17, 2024 |
PKTX / ProtoKinetix, Incorporated / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 21)* PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1409 Peachtree Road Dayton Beach, Florida 32114 (304) 299-5070 (Name, Address and Teleph |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-32917 PROTOKINETIX, INCORPORA |
|
| March 20, 2024 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INCORPORATED (Name of |
|
| March 20, 2024 |
Description of Capital Stock of the Company* Exhibit 4.6 DESCRIPTION OF OUR SECURITIES The following description summarizes important terms of our capital stock and our other securities. For a complete description, you should refer to our Articles of Incorporation and bylaws, forms of which are incorporated by reference to the exhibits to the annual report of which this is a part, as well as the relevant portions of the Nevada Revised Statut |
|
| December 28, 2023 |
PKTX / ProtoKinetix, Incorporated / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment SC 13D/A 1 pktxsmith13da20.htm SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 20)* PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1409 Peachtree Road Dayton Beach, Florida |
|
| October 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-32917 PROTOKINETIX, INCOR |
|
| July 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-32917 PROTOKINETIX, INCORPORAT |
|
| June 15, 2023 |
PKTX / Protokinetix, Inc. / SMITH CLARENCE EDWARD Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 19)* PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1409 Peachtree Road Dayton Beach, Florida 32114 (304) 299-5070 (Name, Addre |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-32917 PROTOKINETIX, INCORPORA |
|
| March 17, 2023 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INCORPORATED (Name of |
|
| March 17, 2023 |
Description of our Securities* Exhibit 4.6 DESCRIPTION OF OUR SECURITIES The following description summarizes important terms of our capital stock and our other securities. For a complete description, you should refer to our Articles of Incorporation and bylaws, forms of which are incorporated by reference to the exhibits to the annual report of which this is a part, as well as the relevant portions of the Nevada Revised Statut |
|
| March 17, 2023 |
Exhibit 4.5 WARRANT AGREEMENT Neither THE WARRANT, NOR THE SHARES UNDERLYING THE WARRANT, GRANTED HEREUNDER TO WHICH THIS WARRANT AGREEMENT RELATES HAVE BEEN REGISTERED UNDER THE securities act of 1933, as amended (the “1933 Act”) AND, UNLESS SO REGISTERED, NONE MAY BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER THE 1933 ACT, PURSUANT TO A |
|
| March 17, 2023 |
Exhibit 4.4 WARRANT AGREEMENT Neither THE WARRANT, NOR THE SHARES UNDERLYING THE WARRANT, GRANTED HEREUNDER TO WHICH THIS WARRANT AGREEMENT RELATES HAVE BEEN REGISTERED UNDER THE securities act of 1933, as amended (the “1933 Act”) OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, NONE MAY BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR TO U.S. PERSONS (AS DEFINED HE |
|
| February 15, 2023 |
PKTX / ProtoKinetix, Inc. / Young Lachlan Grant - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 8)* ProtoKinetix, Incorporated (Name of Issuer) Common Stock, $0.0000053 par value per share (Title of Class Securities) 743722100 (CUSIP NUMBER) December 31, 2022 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designa |
|
| February 15, 2023 |
PKTX / ProtoKinetix, Inc. / Smith Alexandra Blake - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2) ProtoKinetix, Incorporated (Name of Issuer) Common Stock, $0.0000053 par value per share (Title of Class Securities) 743722100 (CUSIP NUMBER) December 31, 2022 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designat |
|
| February 15, 2023 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment SC 13D/A 1 pktxsmith13da18.htm SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 18)* PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1409 Peachtree Road Dayton Beach, Florida |
|
| February 1, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: January 23, 2023 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Commission IRS Employer Incorporation File Number Identification No. 109 W. Main |
|
| January 4, 2023 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: December 30, 2022 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Commission IRS Employer Incorporation File Number Identification No. 109 W. Main |
|
| December 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: December 7, 2022 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Commission IRS Employer Incorporation File Number Identification No. 412 Mulberry |
|
| October 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-32917 PROTOKINETIX, INCOR |
|
| July 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-32917 PROTOKINETIX, INCORPORAT |
|
| May 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-32917 PROTOKINETIX, INCORPORA |
|
| March 21, 2022 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 17)* PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1409 Peachtree Road Dayton Beac, Florida 32114 (304) 299-5070 (Name, Addres |
|
| March 21, 2022 |
Amendment to Amended 2017 Stock Option and Stock Bonus Plan as approved on March 15, 2022(12) Exhibit 4.1 AMENDMENT TO ProtoKinetix, Incorporated Amended 2017 Stock Option and Stock Bonus PLAN Section 5(a) of the Plan is hereby amended as follows: Section 5. Stock Reserved. (a) The stock subject to Awards hereunder shall be shares of Common Stock. Such shares, in whole or in part, may be authorized but unissued shares or shares that shall have been or that may be reacquired by the Corporat |
|
| March 21, 2022 |
PKTX / ProtoKinetix, Inc. / Young Lachlan Grant - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 7)* ProtoKinetix, Incorporated (Name of Issuer) Common Stock, $0.0000053 par value per share (Title of Class Securities) 743722100 (CUSIP NUMBER) December 31, 2021 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designa |
|
| March 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: March 15, 2022 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Commission IRS Employer Incorporation File Number Identification No. 412 Mulberry S |
|
| March 21, 2022 |
PKTX / ProtoKinetix, Inc. / Smith Alexandra Blake - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1) ProtoKinetix, Incorporated (Name of Issuer) Common Stock, $0.0000053 par value per share (Title of Class Securities) 743722100 (CUSIP NUMBER) December 31, 2021 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designat |
|
| March 10, 2022 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INCORPORATED (Name of |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 11, 2022 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Commission IRS Employer Incorporation File Number Identification No. 412 Mulberr |
|
| February 14, 2022 |
Amended and Restated Articles of Incorporation as filed on February 16, 2022(1) Exhibit 4.1 Amended and Restated Articles of Incorporation of ProtoKinetix, Incorporated (the ?Corporation?) Pursuant to the provisions of Nevada Revised Statutes 78.390 and 78.403, the undersigned officer of ProtoKinetix, Incorporated, a Nevada corporation, formerly known as RJV Network, Inc., does hereby certify as follows: A. The Board of Directors of the Corporation has duly adopted resolution |
|
| February 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for use of the Commission only as permitted by Rule 14a-6(e)(2) [ ] Definitive Proxy Statement [X] Definitive Additional Material [ ] Solicitation Material u |
|
| January 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for use of the Commission only as permitted by Rule 14a-6(e)(2) [ ] Definitive Proxy Statement [X] Definitive Additional Material [ ] Solicitation Material u |
|
| December 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for use of the Commission only as permitted by Rule 14a-6(e)(2) [ ] Definitive Proxy Statement [X] Definitive Additional Material [ ] Solicitation Material u |
|
| December 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for use of the Commission only as permitted by Rule 14a-6(e)(2) [X] Definitive Proxy Statement [ ] Definitive Additional Material [ ] Solicitation Material u |
|
| December 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: December 20, 2021 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Commission IRS Employer Incorporation File Number Identification No. 412 Mulberr |
|
| December 23, 2021 |
Amended and Restated Bylaws of the Company as approved on December 20, 2021(2) Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF PROTOKINETIX, INCORPORATED ARTICLE I: OFFICES Section 1.1. Registered Agent and Office. The registered agent of ProtoKinetix, Incorporated (the ?Corporation?) shall be as set forth in the Corporation?s articles of incorporation, as amended or restated (the ?Articles of Incorporation?) and the registered office of the Corporation shall be the street office |
|
| December 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: [X] Preliminary Proxy Statement [ ] Confidential, for use of the Commission only as permitted by Rule 14a-6(e)(2) [ ] Definitive Proxy Statement [ ] Definitive Additional Material [ ] Solicitation Material u |
|
| November 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-32917 PROTOKINETIX, INCOR |
|
| August 6, 2021 |
PKTX / ProtoKinetix, Inc. / Young Lachlan Grant - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 6)* ProtoKinetix, Incorporated (Name of Issuer) Common Stock, $0.0000053 par value per share (Title of Class Securities) 743722100 (CUSIP NUMBER) August 4, 2021 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate |
|
| August 6, 2021 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 16)* PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1845 County Road #214 St. Augustine, Florida 32084 (304) 299-5070 (Name, Address and Tel |
|
| August 6, 2021 |
PKTX / ProtoKinetix, Inc. / Young Lachlan Grant - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 5)* ProtoKinetix, Incorporated (Name of Issuer) Common Stock, $0.0000053 par value per share (Title of Class Securities) 743722100 (CUSIP NUMBER) December 31, 2020 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designa |
|
| July 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-32917 PROTOKINETIX, INCORPORAT |
|
| April 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-32917 PROTOKINETIX, INCORPORA |
|
| March 5, 2021 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 [] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INCORPORATED (Name |
|
| October 16, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-32917 PROTOKINETIX, INCOR |
|
| August 13, 2020 |
PKTX / ProtoKinetix, Inc. / Smith Alexandra Blake - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) ProtoKinetix, Incorporated (Name of Issuer) Common Stock, $0.0000053 par value per share (Title of Class Securities) 743722100 (CUSIP NUMBER) August 4, 2020 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the |
|
| August 10, 2020 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 15)* PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1845 County Road #214 St. Augustine, Florida 32084 (304) 299-5070 (Name, Ad |
|
| July 10, 2020 |
Certificate of Change to the Articles of Incorporation as filed May 1, 2014(11) Exhibit 3.5 |
|
| July 10, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-32917 PROTOKINETIX, INCORPORAT |
|
| July 10, 2020 |
Articles of Amendment to Articles of Incorporation as filed on July 8, 2003(11) Exhibit 3.2 |
|
| July 10, 2020 |
Articles of Amendment to Articles of Incorporation as filed on December 8, 2003(11) Exhibit 3.3 |
|
| July 10, 2020 |
Certificate of Change to the Articles of Incorporation as filed November 16, 2011(11) Exhibit 3.4 |
|
| June 18, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: June 12, 2020 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Commission IRS Employer Incorporation File Number Identification No. 412 Mulberry St |
|
| April 27, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-32917 PROTOKINETIX, INCORPORA |
|
| April 10, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: March 26, 2020 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Commission IRS Employer Incorporation File Number Identification No. 412 Mulberry S |
|
| April 10, 2020 |
Amendment to Amended 2017 Stock Option and Stock Bonus Plan as approved on April 6, 2020(10) Exhibit 4.1 AMENDMENT TO ProtoKinetix, Incorporated Amended 2017 Stock Option and Stock Bonus PLAN Section 5(a) of the Plan is hereby amended as follows: Section 5. Stock Reserved. (a) The stock subject to Awards hereunder shall be shares of Common Stock. Such shares, in whole or in part, may be authorized but unissued shares or shares that shall have been or that may be reacquired by the Corporat |
|
| April 1, 2020 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 14)* PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1845 County Road #214 St. Augustine, Florida 32084 (304) 299-5070 (Name, Ad |
|
| March 31, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: March 25, 2020 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Commission IRS Employer Incorporation File Number Identification No. 412 Mulberry S |
|
| March 31, 2020 |
PKTX / ProtoKinetix, Inc. / Young Lachlan Grant - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 4)* ProtoKinetix, Incorporated (Name of Issuer) Common Stock, $0.0000053 par value per share (Title of Class Securities) 743722100 (CUSIP NUMBER) December 31, 2019 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designa |
|
| February 19, 2020 |
PKTX / ProtoKinetix, Inc. 10-K - Annual Report - FORM 10-K U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 [] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INCORPORATED (Name |
|
| October 26, 2019 |
PKTX / ProtoKinetix, Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 000-32917 PROTOKINETIX, INCOR |
|
| July 26, 2019 |
PKTX / ProtoKinetix, Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: PROTOKINETIX, INCORPORATED (Exact |
|
| July 17, 2019 |
Code of Business Conduct and Ethics and Whistleblower Policy as approved on July 8, 2019(5) Exhibit 14.1 protokinetix, Incorporated CODE OF BUSINESS CONDUCT AND ETHICS AND WHISTLEBLOWER POLICY Adopted by the Board of Directors on July 8, 2019 Introduction ProtoKinetix, Incorporated (the “Company”) is committed to the highest standards of legal and ethical business conduct. This Code of Business Conduct and Ethics and Whistleblower Policy (the “Code”) summarizes the legal, ethical and reg |
|
| July 17, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 8, 2019 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Commission IRS Employer Incorporation File Number Identification No. 412 Mulberry Str |
|
| July 17, 2019 |
Amendment to Amended 2017 Stock Option and Stock Bonus Plan as approved on July 15, 2019(6) Exhibit 4.1 AMENDMENT TO ProtoKinetix, Incorporated Amended 2017 Stock Option and Stock Bonus PLAN Section 5(a) of the Plan is hereby amended as follows: Section 5. Stock Reserved. (a) The stock subject to Awards hereunder shall be shares of Common Stock. Such shares, in whole or in part, may be authorized but unissued shares or shares that shall have been or that may be reacquired by the Corporat |
|
| July 17, 2019 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 13)* PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1845 County Road #214 St. Augustine, Florida 32084 (304) 299-5070 (Name, Ad |
|
| May 7, 2019 |
PKTX / ProtoKinetix, Inc. 10-Q Quarterly Report FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: PROTOKINETIX, INCORPORATED (Exact |
|
| April 16, 2019 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 12)* Under the Securities Exchange Act of 1934 PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1845 County Road #214 St. Augustine, Florida 32084 304-299-5070 (Name, Address and Telep |
|
| March 12, 2019 |
PKTX / ProtoKinetix, Inc. FORM 10-K (Annual Report) U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 [] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INCORPORATED (Name |
|
| February 20, 2019 |
PKTX / ProtoKinetix, Inc. / Young Lachlan Grant - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* ProtoKinetix, Incorporated (Name of Issuer) Common Stock, $0.0000053 par value per share (Title of Class Securities) 743722100 (CUSIP NUMBER) December 31, 2018 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate |
|
| January 2, 2019 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 11)* Under the Securities Exchange Act of 1934 PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1845 County Road #214 St. Augustine, Florida 32084 304-299-5070 (Name, Address and Telep |
|
| November 13, 2018 |
Amended 2017 Stock Option and Stock Bonus Plan(3) Exhibit 4.1 PROTOKINETIX, INCORPORATED AMENDED 2017 STOCK OPTION AND STOCK BONUS PLAN 1. Purposes of and Benefits Under the Plan. This Amended 2017 Stock Option and Stock Bonus Plan (the “Plan”) is intended to encourage stock ownership by employees, consultants, officers and directors of ProtoKinetix, Incorporated and its controlled, affiliated and subsidiary entities (collectively, the “Corporati |
|
| November 13, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: November 9, 2018 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No. 412 Mulberry |
|
| October 26, 2018 |
PKTX / ProtoKinetix, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: PROTOKINETIX, INCORPORATED (E |
|
| July 24, 2018 |
PKTX / ProtoKinetix, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: PROTOKINETIX, INCORPORATED (Exact |
|
| June 12, 2018 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 10)* Under the Securities Exchange Act of 1934 PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1845 County Road #214 St. Augustine, Florida 32084 304-299-5070 (Name, Address and Telep |
|
| April 26, 2018 |
PKTX / ProtoKinetix, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: PROTOKINETIX, INCORPORATED (Exact |
|
| March 9, 2018 |
PKTX / ProtoKinetix, Inc. FORM 10-K (Annual Report) U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 [] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INCORPORATED (Name |
|
| January 22, 2018 |
PKTX / ProtoKinetix, Inc. / Young Lachlan Grant - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* ProtoKinetix, Incorporated (Name of Issuer) Common Stock, $0.0000053 par value per share (Title of Class Securities) 743722100 (CUSIP NUMBER) December 31, 2017 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate |
|
| January 17, 2018 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 9)* Under the Securities Exchange Act of 1934 PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1845 County Road #214 St. Augustine, Florida 32084 304-299-5070 (Name, Address and Teleph |
|
| January 16, 2018 |
Termination of a Material Definitive Agreement, Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: January 12, 2018 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No. 412 Mulberry |
|
| November 14, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: November 14, 2017 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Ide ntification No. 412 Mulber |
|
| November 14, 2017 |
Exhibit 10.1 PROTOKINETIX, INCORPORATED CONSULTING AGREEMENT This CONSULTING AGREEMENT (the ?Agreement?) is made and entered into as of November 14, 2017 (the ?Effective Date?), by and between ProtoKinetix, Incorporated, a Nevada corporation (?Company?), and Michael R. Guzzetta, CPA, an individual (?Consultant?). WHEREAS, the Company is a bio-technology company in the business of developing anti-a |
|
| November 13, 2017 |
Consulting Agreement between the Company and Grant Young, dated December 30, 2016(8) Exhibit 10.13 PROTOKINETIX, INCORPORATED CONSULTING AGREEMENT This CONSULTING AGREEMENT (the “Agreement”) is made and entered into as of December 30, 2016 and made effective as of January 1, 2017 (the “Effective Date”), by and between ProtoKinetix, Incorporated, a Nevada corporation (“Company”), and Grant Young, an individual (“Consultant”). WHEREAS, the Company is a bio-technology company in the |
|
| November 13, 2017 |
PKTX / ProtoKinetix, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: PROTOKINETIX, INCORPORATED (E |
|
| November 9, 2017 |
Exhibit 10.1 SETTLEMENT AGREEMENT AND GENERAL RELEASE This Agreement and General Release (this ?Agreement?) is made and entered into as of the 3 rd day of November 2017, between ProtoKinetix Incorporated, a Nevada corporation, (the ?Company?) and Susan M. Woodward, (the ?Consultant?), an Ohio resident. RECITALS A. The Consultant has provided services to the Company pursuant to a consulting agreeme |
|
| November 9, 2017 |
Exhibit 10.3 THIS UNSECURED PROMISSORY NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR APPLICABLE STATE BLUE SKY OR SECURITIES LAWS AND WAS OFFERED UNDER AN EXEMPTION FROM THE REGISTRATION PROVISIONS OF SUCH LAWS. THIS UNSECURED PROMISSORY NOTE CANNOT BE SOLD, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF EXCEPT IN COMPLIANCE APPLICABLE FEDERAL AND STATE SECURITIES LAWS. Unsecure |
|
| November 9, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: November 3, 2017 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Ide ntification No. 9176 South |
|
| November 9, 2017 |
Exhibit 10.2 THIS UNSECURED PROMISSORY NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR APPLICABLE STATE BLUE SKY OR SECURITIES LAWS AND WAS OFFERED UNDER AN EXEMPTION FROM THE REGISTRATION PROVISIONS OF SUCH LAWS. THIS UNSECURED PROMISSORY NOTE CANNOT BE SOLD, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF EXCEPT IN COMPLIANCE APPLICABLE FEDERAL AND STATE SECURITIES LAWS. Unsecure |
|
| September 12, 2017 |
Exhibit 10.2 AMENDMENT TO DIRECTOR CONSULTING AGREEMENT This Amendment to the Director Consulting Agreement (the ?Amendment?) is entered into on September 1, 2017 (?Effective Date?), by and between Edward P. McDonough (the ?Consultant?) and ProtoKinetix, Incorporated (the ?Company?). RECITALS WHEREAS, the Consultant and the Company entered into that certain Director Consulting Agreement effective |
|
| September 12, 2017 |
Exhibit 10.1 AMENDMENT TO CONSULTING AGREEMENT This Amendment to the Consulting Agreement (the ?Amendment?) is entered into on September 1, 2017 (?Effective Date?), by and between Clarence E. Smith (the ?Consultant?) and ProtoKinetix, Incorporated (the ?Company?). RECITALS WHEREAS, the Consultant and the Company entered into that certain Consulting Agreement effective January 1, 2017 (the ?Consult |
|
| September 12, 2017 |
Exhibit 10.3 AMENDMENT TO CONSULTING AGREEMENT This Amendment to the Consulting Agreement (the ?Amendment?) is entered into on September 1, 2017 (?Effective Date?), by and between Grant Young (the ?Consultant?) and ProtoKinetix, Incorporated (the ?Company?). RECITALS WHEREAS, the Consultant and the Company entered into that certain Consulting Agreement effective January 1, 2017 (the ?Consulting Ag |
|
| September 12, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 1, 2017 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No. 705 Dugan |
|
| September 7, 2017 |
Exhibit 10.1 AMENDMENT TO CONSULTING AGREEMENT This Amendment to the Consulting Agreement (the ?Amendment?) is entered into on September 1, 2017 (?Effective Date?), by and between Clarence E. Smith (the ?Consultant?) and ProtoKinetix, Incorporated (the ?Company?). RECITALS WHEREAS, the Consultant and the Company entered into that certain Consulting Agreement effective January 1, 2017 (the ?Consult |
|
| September 7, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 1, 2017 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No. 705 Dugan R |
|
| September 7, 2017 |
Exhibit 10.2 AMENDMENT TO DIRECTOR CONSULTING AGREEMENT This Amendment to the Director Consulting Agreement (the ?Amendment?) is entered into on September 1, 2017 (?Effective Date?), by and between Edward P. McDonough (the ?Consultant?) and ProtoKinetix, Incorporated (the ?Company?). RECITALS WHEREAS, the Consultant and the Company entered into that certain Director Consulting Agreement effective |
|
| September 7, 2017 |
Exhibit 10.3 AMENDMENT TO CONSULTING AGREEMENT This Amendment to the Consulting Agreement (the ?Amendment?) is entered into on September 1, 2017 (?Effective Date?), by and between Grant Young (the ?Consultant?) and ProtoKinetix, Incorporated (the ?Company?). RECITALS WHEREAS, the Consultant and the Company entered into that certain Consulting Agreement effective January 1, 2017 (the ?Consulting Ag |
|
| August 8, 2017 |
PKTX / ProtoKinetix, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: PROTOKINETIX, INCORPORATED (Exact |
|
| May 12, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 OR ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: PROTOKINETIX, INCORPORATED (Exact |
|
| February 21, 2017 |
2017 Stock Option and Stock Bonus Plan3 Exhibit 4.2 PROTOKINETIX, INCORPORATED 2017 STOCK OPTION AND STOCK BONUS PLAN 1. Purposes of and Benefits Under the Plan. This 2017 Stock Option and Stock Bonus Plan (the "Plan") is intended to encourage stock ownership by employees, consultants, officers and directors of ProtoKinetix, Incorporated and its controlled, affiliated and subsidiary entities (collectively, the "Corporation"), so that th |
|
| February 21, 2017 |
Consulting Agreement between the Company and Clarence E. Smith, dated December 30, 2016(7) Exhibit 10.9 PROTOKINETIX, INCORPORATED CONSULTING AGREEMENT This CONSULTING AGREEMENT (the "Agreement") is made and entered into as of December 30, 2016 and made effective as of January 1, 2017 (the "Effective Date"), by and between ProtoKinetix, Incorporated, a Nevada corporation ("Company"), and Clarence E. Smith, an individual ("Consultant"). WHEREAS, the Company is a bio-technology company in |
|
| February 21, 2017 |
Consulting Agreement between the Company and Susan M. Woodward, dated December 30, 20163 Exhibit 10.10 PROTOKINETIX, INCORPORATED CONSULTING AGREEMENT This CONSULTING AGREEMENT (the "Agreement") is made and entered into as of December 30, 2016 and made effective as of January 1, 2017 (the "Effective Date"), by and between ProtoKinetix, Incorporated, a Nevada corporation ("Company"), and Susan M. Woodward, an individual ("Consultant"). WHEREAS, the Company is a bio-technology company i |
|
| February 21, 2017 |
Exhibit 10.11 PROTOKINETIX, INCORPORATED DIRECTOR CONSULTING AGREEMENT This DIRECTOR CONSULTING AGREEMENT (the "Agreement") is made and entered into as of December 30, 2016 and made effective as of January 1, 2017 (the "Effective Date"), by and between ProtoKinetix, Incorporated, a Nevada corporation ("Company"), and Edward P. McDonough, an individual (the "Director"). WHEREAS, the Company is a bi |
|
| February 21, 2017 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 [] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INCORPORATED (Name |
|
| January 24, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: January 17, 2017 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No. 9176 South P |
|
| January 5, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: November 30, 2016 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No. 9176 South |
|
| January 5, 2017 |
PKTX / ProtoKinetix, Inc. / Young Lachlan Grant - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* ProtoKinetix, Incorporated (Name of Issuer) Common Stock, $0.0000053 par value per share (Title of Class Securities) 743722100 (CUSIP NUMBER) January 1, 2017 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate t |
|
| December 23, 2016 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment SC 13D/A 1 pktx13da.htm SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 8)* Under the Securities Exchange Act of 1934 PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1845 County Road #214 St. Augustine, Florida 32084 |
|
| December 22, 2016 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 7)* Under the Securities Exchange Act of 1934 PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1845 County Road #214 St. Augustine, Florida 32084 304-299-5070 (Name, Address and Teleph |
|
| December 7, 2016 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 6)* Under the Securities Exchange Act of 1934 PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1845 County Road #214 St. Augustine, Florida 32084 304-299-5070 (Name, Address and Teleph |
|
| November 14, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: PROTOKINETIX, INCORPORATED (E |
|
| November 8, 2016 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment SC 13D/A 1 pktx13da.htm SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 5)* Under the Securities Exchange Act of 1934 PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1845 County Road #214 St. Augustine, Florida 32084 |
|
| September 19, 2016 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment SC 13D/A 1 pktx13da.htm SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 4)* Under the Securities Exchange Act of 1934 PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1845 County Road #214 St. Augustine, Florida 32084 |
|
| August 15, 2016 |
Universal Agreement between the Company and Grant Young, dated May 20, 20169 Exhibit 10.9 UNIVERSAL ASSIGNMENT WHEREAS I, Grant YOUNG, whose full address is: - 6438 Rosebery Avenue, West Vancouver, BC V7W 2C6 Canada; has invented certain new and useful improvements in an invention entitled "USE OF ANTI-AGING GLYCOPROTEIN FOR ENHANCING SURVIVAL OF NEUROSENSORY PRECURSOR CELLS" for which a patent application(s) was / were filed as listed on Schedule A attached hereto. AND WH |
|
| August 15, 2016 |
Exhibit 10.11 |
|
| August 15, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: PROTOKINETIX, INCORPORATED (Exact |
|
| August 15, 2016 |
Exhibit 10.11 |
|
| August 15, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: PROTOKINETIX, INCORPORATED (Exact |
|
| August 15, 2016 |
Exhibit 10.10 COLLABORATIVE RESEARCH AGREEMENT BETWEEN: THE UNIVERSITY OF BRITISH COLUMBIA, a corporation continued under the University Act of British Columbia with offices at 103 – 6190 Agronomy Road, Vancouver, British Columbia, V6T 1Z3 (“UBC”) AND VANCOUVER COASTAL HEALTH AUTHORITY, a regional health board established under the Health Authorities Act (British Columbia) having its research admi |
|
| July 11, 2016 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 3)* Under the Securities Exchange Act of 1934 PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1845 County Road #214 St. Augustine, Florida 32084 304-299-5070 (Name, Address and Teleph |
|
| June 16, 2016 |
Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: June 16, 2016 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No. 9176 South Plea |
|
| June 7, 2016 |
Exhibit 99.1 ProtoKinetix? AAGP? has been Published in the Journal of Tissue Engineering and Regenerative Medicine St. Marys, West Virginia, June 7, 2016 ProtoKinetix, Incorporated (OTCQB: PKTX) (the "Company" or "ProtoKinetix") ( www.protokinetix.com) is pleased to announce that a paper submitted by Dr. Kevin Gregory-Evans on ProtoKinetix? AAGP? has been published in the Journal of Tissue Enginee |
|
| June 7, 2016 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 20, 2016 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No. 9176 South Pleas |
|
| May 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: PROTOKINETIX, INCORPORATED (Exact |
|
| May 16, 2016 |
Exhibit 10.8 ITR MASTER CONTRACT By and Between: ITR Laboratories Canada Inc. 19601 boul. Clark Graham, Baie d?Urfe, Quebec, H9X 3T1, Canada Tel: (514) 457-7400 Fax: (514) 457-7303 (?ITR?) By and Between: The Sponsor Name: ProtoKinetix, Incorporated Address: 9176 South Pleasants Highway Tel: 304-299-5070 Contact Person: Clarence E. Smith Title: President and CEO E-mail: [email protected] (th |
|
| May 5, 2016 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 2)* Under the Securities Exchange Act of 1934 PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1845 County Road #214 St. Augustine, Florida 32084 304-299-5070 (Name, Address and Teleph |
|
| May 3, 2016 |
Form 51-105Fl Notice -OTC Issuer Ceases to be an OTC Reporting Issuer Exhibit 99.1 Form 51-105Fl Notice -OTC Issuer Ceases to be an OTC Reporting Issuer This is the form required under paragraph 4 (1) (d) of Multilateral Instrument 51-105 Issuers Quoted in the Us. Over-the-Counter Markets for an a TC issuer to give notice that it has ceased to be an aTC reporting issuer under section 3 of the Instrument in a jurisdiction other than Quebec. In Quebec, an aTC reportin |
|
| May 3, 2016 |
ProtoKinetix FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 2, 2016 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No. 9176 South Pleasa |
|
| May 3, 2016 |
AAGP™ Improves Results in Stem Cells Transplanted in Retina Tissue by 300% Exhibit 99.2 AAGP? Improves Results in Stem Cells Transplanted in Retina Tissue by 300% St. Marys, West Virginia, May 2, 2016 ProtoKinetix, Incorporated (OTCQB: PKTX) (the "Company" or "ProtoKinetix") ( www.protokinetix.com) is pleased to announce that a paper submitted by Dr. Kevin Gregory-Evans on ProtoKinetix? AAGP? has been accepted by the Journal of Tissue Engineering and Regenerative Medicin |
|
| April 26, 2016 |
ProtoKinetix Outlines Steps to Clinical Trial Application for AAGP™ Exhibit 99.1 ProtoKinetix Outlines Steps to Clinical Trial Application for AAGP? St. Marys, West Virginia, April 26, 2016 ProtoKinetix, Incorporated (OTCQB: PKTX) (the "Company" or "ProtoKinetix") ( www.protokinetix.com) outlines the steps to be completed for the application to conduct a clinical trial in Canada. For the last four years ProtoKinetix has been involved in a collaboration with the La |
|
| April 26, 2016 |
ProtoKinetix FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 26, 2016 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No. 9176 South Ple |
|
| April 22, 2016 |
PKTX / ProtoKinetix, Inc. / Young Lachlan Grant - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ProtoKinetix, Incorporated (Name of Issuer) Common Stock, $0.0000053 par value per share (Title of Class Securities) 743722100 (CUSIP NUMBER) January 1, 2016 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate th |
|
| March 30, 2016 |
PROTOKINETIX, INCORPORATED CONSULTING AGREEMENT EX-10.6 3 ex10x6.htm EXHIBIT 10.6 Exhibit 10.6 PROTOKINETIX, INCORPORATED CONSULTING AGREEMENT This CONSULTING AGREEMENT (the “Agreement”) is made and entered into as of December 21, 2015 and made effective as of January 1, 2016 (the “Effective Date”), by and between ProtoKinetix, Incorporated, a Nevada corporation (“Company”), and Susan M. Woodward, an individual (“Consultant”). WHEREAS, the Comp |
|
| March 30, 2016 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INCORPORATED (Name |
|
| March 30, 2016 |
PROTOKINETIX, INCORPORATED DIRECTOR CONSULTING AGREEMENT Exhibit 10.7 PROTOKINETIX, INCORPORATED DIRECTOR CONSULTING AGREEMENT This DIRECTOR CONSULTING AGREEMENT (the ?Agreement?) is made and entered into as of December 23, 2015 and made effective as of January 1, 2016 (the ?Effective Date?), by and between ProtoKinetix, Incorporated, a Nevada corporation (?Company?), and Edward P. McDonough, an individual (the ?Director?). WHEREAS, the Company is a bio |
|
| March 30, 2016 |
PROTOKINETIX, INCORPORATED CONSULTING AGREEMENT Exhibit 10.5 PROTOKINETIX, INCORPORATED CONSULTING AGREEMENT This CONSULTING AGREEMENT (the ?Agreement?) is made and entered into as of December 21, 2015 and made effective as of January 1, 2016 (the ?Effective Date?), by and between ProtoKinetix, Incorporated, a Nevada corporation (?Company?), and Clarence E. Smith, an individual (?Consultant?). WHEREAS, the Company is a bio-technology company in |
|
| January 6, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: December 21, 2015 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No. 9176 South |
|
| January 6, 2016 |
Exhibit 99.1 ProtoKinetix Corporate Update St. Marys, West Virginia, January 5, 2016 ProtoKinetix, Incorporated (OTCQB: PKTX) (the "Company" or "ProtoKinetix") ( www.protokinetix.com) is pleased to provide the following corporate update to its stockholders: Fiscal 2015 was a year of significant progress for ProtoKinetix, Incorporated. We executed several complex initiatives and continued to make g |
|
| November 16, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 OR ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: PROTOKINETIX, INCORPORATED (E |
|
| August 14, 2015 |
2015 Stock Option and Stock Bonus Plan2 Exhibit 4.1 PROTOKINETIX, INCORPORATED 2015 STOCK OPTION AND STOCK BONUS PLAN 1. Purposes of and Benefits Under the Plan. This 2015 Stock Option and Stock Bonus Plan (the "Plan") is intended to encourage stock ownership by employees, consultants, officers and directors of ProtoKinetix, Incorporated and its controlled, affiliated and subsidiary entities (collectively, the "Corporation"), so that th |
|
| August 14, 2015 |
PROTOKINETIX, INCORPORATED DIRECTOR CONSULTING AGREEMENT Exhibit 10.3 PROTOKINETIX, INCORPORATED DIRECTOR CONSULTING AGREEMENT This DIRECTOR CONSULTING AGREEMENT (the "Agreement") is made and entered into as of July 1, 2015 (the "Effective Date"), by and between ProtoKinetix, Incorporated, a Nevada corporation ("Company"), and Edward P. McDonough, an individual the ("Director"). WHEREAS, the Company is a bio-technology company in the business of develop |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: PROTOKINETIX, INCORPORATED (Exact |
|
| July 8, 2015 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 1)* Under the Securities Exchange Act of 1934 PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1845 County Road #214 St. Augustine, Florida 32084 304-299-5070 (Name, Address and Teleph |
|
| July 7, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: June 30, 2015 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No. 9176 South Plea |
|
| May 20, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 OR ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: PROTOKINETIX, INCORPORATED (Exact |
|
| May 20, 2015 |
EX-10.6 2 ex10x6.htm EXHIBIT 10.6 Exhibit 10.6 TECHNOLOGY TRANSFER AGREEMENT THIS AGREEMENT made as of the 22nd day of April, 2015. BETWEEN: GRANT YOUNG, having an address for delivery and service located at 6438 Rosebery, West Vancouver, BC V7W 2C6 (the “Consultant”); OF THE FIRST PART AND: PROTOKINETIX, INC. a Nevada company having its address for notices hereunder at c/o 9176 South Pleasant Hig |
|
| May 18, 2015 |
ProtoKinetix NOTIFICATION OF LATE FILING photont10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER CUSIP NUMBER NOTIFICATION OF LATE FILING (Check one:) ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR For Period Ended: March 31, 2015 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on For |
|
| May 1, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 30, 2015 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No. 9176 South Ple |
|
| April 27, 2015 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 22, 2015 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No. 9176 South Ple |
|
| April 14, 2015 |
PROTOKINETIX, INCORPORATED CONSULTING AGREEMENT Exhibit 10.5 PROTOKINETIX, INCORPORATED CONSULTING AGREEMENT This CONSULTING AGREEMENT (the ?Agreement?) is made and entered into as of March 30, 2015 and made effective as of January 1, 2015 (the ?Effective Date?), by and between ProtoKinetix, Incorporated, a Nevada corporation (?Company?), and Susan M. Woodward, an individual (?Consultant?). WHEREAS, the Company is a bio-technology company in th |
|
| April 14, 2015 |
Exhibit 10.2 INSI INSTITUT NATIONAL DES SCIENCES APPLIQUEES ROUEN Saint Etienne du Rouvray, Ie 28 Octobre 2014 Direction de la Recherche et de la Valorisation Affaire suivie par Mme JOUETTE/Mme VANDER EECKEN Tel: 02 32 95 66 62 [email protected] Objet: Cession de brevets Monsieur, L'INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE ROUEN(INSA) de 685 avenue de l'Universite, BP08, 76801, Sain |
|
| April 14, 2015 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INCORPORATED (Name of |
|
| April 14, 2015 |
Exhibit 10.6 ROYALTY AGREEMENT This agreement made as of the 23rd day of March, 2015 ("Effective Date") BETWEEN: Protokinetix Incorporated a corporation pursuant to the laws of Nevada having an address for receipt of notices at 9176 South Pleasants Highway, St. Marys, WV, USA 26170 (hereinafter called "Protokinetix") The Governors of The University Of Alberta a university incorporated under the Po |
|
| April 14, 2015 | ||
| April 14, 2015 |
PROTOKINETIX, INCORPORATED CONSULTING AGREEMENT Exhibit 10.4 PROTOKINETIX, INCORPORATED CONSULTING AGREEMENT This CONSULTING AGREEMENT (the ?Agreement?) is made and entered into as of March 30, 2015 and made effective as of January 1, 2015 (the ?Effective Date?), by and between ProtoKinetix, Incorporated, a Nevada corporation (?Company?), and Clarence E. Smith, an individual (?Consultant?). WHEREAS, the Company is a bio-technology company in th |
|
| April 14, 2015 |
SETTLEMENT AND INDEMNITY AGREEMENT IBIS AGREEMENT dated for reference 2nd day of March, 2015. Exhibit 10.3 SETTLEMENT AND INDEMNITY AGREEMENT IBIS AGREEMENT dated for reference 2nd day of March, 2015. BETWEEN: Protokinetix, Inc. having a business address at 9176 South Pleasant Highway, St. Marys, West Virginia, USA261 70 (the "Company") AND OF THE FIRST PART Standard Bankcorp Inc. having a business address at 6528 Wellington Place, West Vancouver, BC V7W 2Jl (the "Creditor") OF THE SECOND |
|
| April 14, 2015 | ||
| April 14, 2015 |
ProtoKinetix FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 8, 2015 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No. 9176 South Plea |
|
| April 7, 2015 |
Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 3, 2015 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No. 9176 South Plea |
|
| April 3, 2015 |
ProtoKinetix FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: March 30, 2015 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No. 9176 South Ple |
|
| April 1, 2015 |
ProtoKinetix NOTIFICATION OF LATE FILING photont10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER CUSIP NUMBER NOTIFICATION OF LATE FILING (Check one:) ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR For Period Ended: December 31, 2014 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on |
|
| March 25, 2015 |
PKTX / ProtoKinetix, Inc. / SMITH CLARENCE EDWARD - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 PROTOKINETIX, INCORPORATED (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Class of Securities) 743722100 (CUSIP Number) Clarence E. Smith 1845 County Road #214 St. Augustine, Florida 32084 304-299-5070 (Name, Address and Telephone Number of Person |
|
| March 9, 2015 |
ProtoKinetix FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: March 2, 2015 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No 9176 South Pleas |
|
| February 26, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 25, 2015 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No. 9176 South |
|
| February 24, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 19, 2015 ProtoKinetix, Incorporated (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 State of Incorporation Commission File Number IRS Employer Identification No 9176 South P |
|
| November 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE C OMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94 |
|
| November 6, 2014 |
Converted by EDGARwiz |
|
| November 6, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) October 27 2014 - PROTOKINETIX, INC. |
|
| November 6, 2014 |
October 27, 2014 October 27, 2014 Intrepid Innovations Corporation 4654 SR 64 E Penthouse Suite 127 Bradenton, Florida 34208 Gentlemen: ProtoKinetix hereby declares the Agreement to Sell Rights for AAGP Blood Preservative Applications (“Agreement”) made March 4, 2014, to be null and void. |
|
| October 8, 2014 |
United States Securities and Exchange Commission Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15[d] of the Securities Exchange Act of 1934 October 8, 2014 Date of Report PROTOKINETIX, INC. (Exact name of Registrant as specified in its Charter) Nevada 000-32917 94-3355026 (State or Other Jurisdiction of (Commission File Number) (I.R.S. Employer Identification No.) Incorp |
|
| August 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE C OMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355 |
|
| June 25, 2014 |
Protokinetix, Inc.: Form 8-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 25, 2014 PROTOKINETIX, INC. (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 (State or o |
|
| June 5, 2014 |
UNTED STATES SECURITIES AND EXCHANGE C OMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355 |
|
| May 27, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INC. (Name |
|
| May 15, 2014 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2013 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355026 |
|
| May 14, 2014 |
10-Q 1 form10q.htm FORM 10-Q U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX |
|
| May 14, 2014 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355026 (Stat |
|
| April 30, 2014 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INC. (Name of smal |
|
| November 15, 2012 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30,2012 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355026 ( |
|
| November 15, 2012 |
Protokinetix, Inc.: Form 12b-25 - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ x ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: September 30, 2012 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Tr |
|
| August 20, 2012 |
UNITED STATES SECURITIES AND EXCHANGE C OMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2012 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-33 |
|
| August 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE C OMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30,2012 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-33550 |
|
| May 15, 2012 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355026 (Sta |
|
| March 20, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INC. (Name |
|
| February 14, 2012 |
PKTX / ProtoKinetix, Inc. / Empire Capital Management, L.L.C. Passive Investment FORM SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Amendment No.6 PROTOKINETIX INC (Name of Issuer) Common Stock, $0.0000053 par value per share (Title of Class of Securities) 743722100 (CUSIP Number) December 31, 2011 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this Schedule 13G is fi |
|
| November 14, 2011 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355026 |
|
| August 15, 2011 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355026 (Stat |
|
| May 16, 2011 |
UNITED STATES SECURITIES AND EXCHANGE C OMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2011 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-335 |
|
| March 29, 2011 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2010 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INC. (Name of smal |
|
| February 15, 2011 |
SECURITIES & EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Amendment No. 5 INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) UNDER THE SECURITIES EXCHANGE ACT OF 1934 PROTOKINETIX INC (Name of Issuer) Common Stock, $0.0000053 par value (Title of Class of Securities) 743722100 (CUSIP Numb |
|
| January 24, 2011 |
January 24, 2011 United States Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Attention: Jim B. |
|
| January 24, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2009 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INC. (Na |
|
| December 14, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2009 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INC. (Na |
|
| December 14, 2010 |
December 9, 2010 VIA EDGAR FILING United States Securities and Exchange Commission 100 F Street, N. |
|
| November 8, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2010 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. (Exact nam |
|
| August 11, 2010 |
U. S. SECURITIES AND EXCHANGE C OMMISSION WASHINGTON, D.C. 20549 FORM 10-Q U. S. SECURITIES AND EXCHANGE C OMMISSION WASHINGTON, D.C. 20549 FORM 10-Q T QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2010 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355026 (State o |
|
| May 14, 2010 |
U. S. SECURITIES AND EXCHANGE C OMMISSION WASHINGTON, D.C. 20549 FORM 10-Q U. S. SECURITIES AND EXCHANGE C OMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2010 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355026 (State |
|
| March 11, 2010 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K T ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2009 £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INC. (Name of small bu |
|
| February 16, 2010 |
SECURITIES & EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Amendment No. 4 INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) UNDER THE SECURITIES EXCHANGE ACT OF 1934 PROTOKINETIX INC (Name of Issuer) Common Stock, $0.0000053 par value (Title of Class of Securities) 743722100 (CUSIP Numb |
|
| November 13, 2009 |
U. S. SECURITIES AND EXCHANGE C OMMISSION WASHINGTON, D.C. 20549 FORM 10-Q U. S. SECURITIES AND EXCHANGE C OMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2009 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355026 (St |
|
| August 6, 2009 |
U. S. SECURITIES AND EXCHANGE C OMMISSION WASHINGTON, D.C. 20549 FORM 10-Q U. S. SECURITIES AND EXCHANGE C OMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2009 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355026 (State o |
|
| May 15, 2009 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K T ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2008 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INC. (Name of small bu |
|
| May 15, 2009 |
U. S. SECURITIES AND EXCHANGE C OMMISSION WASHINGTON, D.C. 20549 FORM 10-Q T QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2009 £ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355026 (State |
|
| May 7, 2009 |
Changes in Registrant's Certifying Accountant 8-K/A 1 form8ka.htm PROTOKINETIX, INC 8KA 4-17-2008 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A AMENDED CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 17, 2008 PROTOKINETIX, INC. (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 (Stat |
|
| May 7, 2009 |
May 6, 2009 Protokinetix, Inc. 2225 Folkstone Way West Vancouver, British Columbia V7S 2Y6 United States Securities and Exchange Commission 100 F Street NE Washington, D.C. 20549-7010 Attention: Tabatha Akins, Staff Accountant Re: Protokinetix, Inc.; Item 4.01 Form 8-K; filed April 20, 2009; file number 000.32917 Dear Ms. Akins: Please be informed that we have received and reviewed your letter dat |
|
| May 1, 2009 |
May 1, 2009 Protokinetix, Inc. 2225 Folkstone Way West Vancouver, British Columbia V7S 2Y6 United States Securities and Exchange Commission 100 F Street NE Washington, D.C. 20549-7010 Attention: Tabatha Akins, Staff Accountant Re: Protokinetix, Inc.; your file number 000-32917 Dear Ms. Akins: Please be informed that we have received and reviewed your letter dated April 23, 2009, regarding our Form |
|
| April 20, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 17, 2008 PROTOKINETIX, INC. (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 (State or other jurisdiction of incorporation) (Commission File Num |
|
| March 31, 2009 |
United States Securities and Exchange Commission Washington, D.C. 20549 FORM 12b-25 Notification of Late Filing (Amendment No. 0)* OMB Number 3234-0058 SEC File Number CUSIP Number (Check one): ? Form 10-K Form 20-F Form 11-K Form 10-Q Form 10-D Form N-SAR Form N-CSR For Period Ended: December 31, 2008 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Tra |
|
| February 13, 2009 |
OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response. |
|
| November 13, 2008 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2008 £ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355026 (Sta |
|
| August 15, 2008 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2008 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355026 (State or |
|
| August 15, 2008 |
United States Securities and Exchange Commission Washington, D.C. 20549 FORM 12b-25 Notification of Late Filing (Amendment No. 0)* OMB Number 3234-0058 SEC File Number CUSIP Number (Check one): Form 10-K Form 20-F Form 11-K ? Form 10-Q Form 10-D Form N-SAR Form N-CSR For Period Ended: June 30, 2008 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transit |
|
| May 20, 2008 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2008 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355026 (Sta |
|
| May 15, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [ ] Form 10-KSB [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form N-SAR For Period Ended: [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form N-SAR For th |
|
| May 2, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB/A [ X ] Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2004, or [ ] Transitional Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File No. 0-32917 PROTOKINETIX, INC. Formerly known as |
|
| May 2, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A (Mark One) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A (Mark One) [ X ] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2004 or [ ] Transitional Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File No. 0-32917 PROTOKINETIX, INC. a |
|
| May 2, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FIRST AMENDED FORM 10-KSB/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FIRST AMENDED FORM 10-KSB/A (Mark One) [ X ] Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2003. [ ] Transitional Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File No. 0-32917 PROTOKINETIX, |
|
| May 1, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A (Mark One) [ X ] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2005 or [ ] Transitional Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period Commission File No. 0-32917 PROTOKINETIX, INC. (Name of sma |
|
| May 1, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A [ X ] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2005 or [ ] Transitional Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File No. 0-32917 PROTOKINETIX, INC. (Name of small |
|
| May 1, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A [ X ] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2005 or [ ] Transitional Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File No. 0-32917 PROTOKINETIX, INC. (Name of |
|
| May 1, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A [ X ] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2004 or [ ] Transitional Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File No. 0-32917 PROTOKINETIX, INC. a develop |
|
| May 1, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A [ X ] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2004 or [ ] Transitional Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File No. 000-32917 PROTOKINETIX, INC. a developmen |
|
| April 30, 2008 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB/A U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB/A [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2006 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355 |
|
| April 30, 2008 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB/A U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB/A [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2006 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355026 ( |
|
| April 30, 2008 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB/A U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB/A [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2006 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355026 |
|
| April 15, 2008 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2007 [X] TRANSITIONAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32917 PROTOKINETIX, INC. (Name of |
|
| March 28, 2008 |
NT 10-K 1 pktx12b25123107.htm PKTX 12B-25 (12-31-07) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [X] Form 10-KSB [ ] Form 20-F [ ] Form 11-K [ ] Form 10-QSB [ ] Form N-SAR For Period Ended: December 31, 2007 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Tr |
|
| March 26, 2008 |
United States Securities and Exchange Commission United States Securities and Exchange Commission 100 F Street, N.E. Mail Stop 3561 Washington, D.C. 20549 Attention: Brian K. Bhandari March 26, 2008 RE: Registrant Name: Protokinetix, Inc. (the ?Company?) File No. 000-32917 Dear Mr. Bhandari: Further to our telephone conversation on March 18, 2008 and your letter dated March 17, 2008, the company has made the changes to all corporate filings iden |
|
| February 14, 2008 |
SC 13G/A 1 c72216sc13gza.htm SCHEDULE 13G/A OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response...10.4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* PROTOKINETIX INC COM (Name of Issuer) Common Stock, par value $0.0000053 per share (Title of Clas |
|
| November 14, 2007 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2007 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-335502 |
|
| September 14, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Registration No. 333-125844 Washington, D.C. 20549 POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT FILED PURSUANT TO THE SECURITIES ACT OF 1933 Date of Report: September 13, 2007 PROTOKINETIX, INC. (Exact name of registrant as specified in its charter) Nevada 94-3355026 (State or other jurisdiction of incorporation or organization) |
|
| September 14, 2007 |
PROTOKINETIX, INC. 2005 FIRST AMENDED STOCK INCENTIVE PLAN PROTOKINETIX, INC. 2005 FIRST AMENDED STOCK INCENTIVE PLAN 1. Purpose of the Plan. The purpose of the 2005 First Amended Stock Incentive Plan (the ?Plan?) of ProtoKinetix, Inc., a Nevada corporation, (?Company?) is to provide the Company with a means of compensating selected key employees (including officers) and directors of and consultants to the Company (sometimes referred to hereinafter as ?Pa |
|
| August 21, 2007 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB/A U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB/A [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2007 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355026 ( |
|
| August 20, 2007 |
U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2007 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-32917 PROTOKINETIX, INC. Nevada 94-3355026 (St |
|
| August 14, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [ ] Form 10-KSB [ ] Form 20-F [ ] Form 11-K [X] Form 10-QSB [ ] Form N-SAR For Period Ended: June 30, 2007 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on For |
|
| August 13, 2007 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 1, 2007 PROTOKINETIX, INC. (Exact name of registrant as specified in its charter) Nevada 000-32917 94-3355026 (State or other jurisdiction (Commission File Number) (IRS Employer of Incorporat |
|
| August 13, 2007 |
August 1, 2007 To the Board of Directors of ProtoKinetix, Inc.: I want to extend my appreciation for the offer you have made in connection with my appointment to the position of member of the Board of Directors of ProtoKinetix, Inc. Please consider this letter my formal acceptance of this offer for appointment as a member of the Board of Directors. Best regards, /s/ Dr. Maximilien Arella Dr. Maxim |
|
| August 13, 2007 |
August 1, 2007 To the Board of Directors of ProtoKinetix, Inc.: I want to extend my appreciation for the offer you have made in connection with my appointment to the position of President and Chief Executive Officer of ProtoKinetix, Inc. Please consider this letter my formal acceptance of this offer for appointment as President and Chief Executive Officer. Best regards, /s/ Ross L. Senior Ross L. |
|
| August 13, 2007 |
August 1, 2007 To the Board of Directors of ProtoKinetix, Inc.: I, Mark L. Baum, Esq., hereby tender my resignation from the position of interim President and Director of ProtoKinetix, Inc. (the ?Company?), effective immediately. My resignation is not because of any disagreement with the Company on any matters relating to the Company?s operations, policies, disclosures and/or practices. Best regar |
|
| June 4, 2007 |
May 28, 2007 To the Board of Directors of ProtoKinetix, Inc.: I, Dr. John Todd, hereby tender my resignation from the positions of President, Chief Executive Officer, Chief Financial Officer and Director of ProtoKinetix, Inc. (the ?Company?), effective immediately. My resignation is not because of any disagreement with the Company on any matters relating to the Company?s operations, policies, disc |
